Jesse Goodman, head of the Center for Biologic Evaluation & Research, is taking on a more prominent role within the Food & Drug Administration as the agency realigns its management in anticipation of the arrival of Commissioner-designate Margaret Hamburg and her principal deputy Joshua Sharfstein.
Goodman has been named acting Chief Medical Officer in the Office of the Commissioner. The position was created in 2007...






